Cyclohexanol/ Cyclohexanone

Introduction

Executive Overview

Strategic Insights

• Oversupply of caprolactam and adipic acid in mainland China will take a long time to absorb and lead to uneven developments across regions
• The global cyclohexane market will remain structurally long for the next decade
• The ADN business will face a structural shift once ADN capacity additions come onstream in mainland China. North American ADN producers will face the brunt of the emerging competition
• Non-nylon demand for ADA and HMDA will remain generally strong, despite some ongoing substitution in the PU market
• Recycling and environmental sustainability will have only minor impacts on demand for conventional feedstocks in the near term
• Biogenerated ADA, CPL, and HMDA are in various stages of development,
  but the impact in the near term is minimal

North America

South America

West Europe

Central Europe

CIS & Baltic States

Africa

Middle East

Indian Subcontinent